Zepp Health Corporation Zepp Health or the Company NYSE Zepp , a global leader in smart wearables and health technology, today announced that it will report its third quarter 2026 unaudited financial results on Sunday, N
Why Is Zepp Health Corporation American depositary shares, each representing sixteen (ZEPP) Stock Down Today?
Updated Nov 22, 2026 5:31 AM ET ยท Prev Close $2.52
Session Regime & Catalyst Assessment
68% Signal ConvictionZepp Health Corporation American depositary shares, each representing sixteen Pulling Back 8.33% on 1.41x Relative Volume
Zepp Health Corporation American depositary shares, each representing sixteen (ZEPP) is pulling back 8.33% (-$0.21) to $2.31 on 1.41x average session volume. Relative to benchmarks, ZEPP is lagging the S&P 500 by -4.69%. 14-day RSI stands at 35.4, keeping momentum in a bearish regime.
Zepp Health Corporation Zepp Health or the Company NYSE Zepp , a global leader in smart wearables and health technology, today announced that it will report its third quarter 2026 unaudited financial results on Sunday, N
Price ($2.31) trades relative to 20-day SMA ($2.40) and 50-day SMA ($3.21).
Market & Sector Relative Strength
ZEPP lagging the S&P 500 by -4.69%Options Flow & Execution Desk
Recent ZEPP Catalyst Headlines
Verified WireZepp Health Corp ZEPP reports a 6.9 revenue increase to 63.5 million, but guides Q3 lower due to supply bottlenecks and macroeconomic headwinds.
Zepp Health NYSE Zepp reported second-quarter 2026 revenue of 63.5 million, up 6.9 from a year earlier, as new product launches and a higher-priced product mix supported growth. Gross margin improved to 37.4 from 36.2 a
Zepp Health Corporation NYSE Zepp Zepp , the Company or we today announced its unaudited financial results for the second quarter of 2026.
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $2.40 (20-day SMA resistance) for directional breakout confirmation.
Technical Regime (ZEPP)
BEARISH MA TRENDRetail & Crowd Sentiment
NeutralAbout Zepp Health Corporation American depositary shares, each representing sixteen
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
Get Instant ZEPP Catalyst Alerts
Receive an email alert when ZEPP triggers an unusual volume breakout, options sweep, or rating shift.
ZEPP Session & Catalyst FAQ
Why is ZEPP stock down today?
Zepp Health Corporation American depositary shares, each representing sixteen (ZEPP) is pulling back 8.33% (-$0.21) to $2.31 on 1.41x average session volume. Relative to benchmarks, ZEPP is lagging the S&P 500 by -4.69%. 14-day RSI stands at 35.4, keeping momentum in a bearish regime.
Is ZEPP stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 1.41x relative volume (moderate participation). Our multi-factor model currently rates ZEPP as BUY. Review full valuation, quality, and timing signals on the ZEPP Buy or Sell Decision Brief โ
What is ZEPP's intrinsic value and expected trading range?
At $2.31, ZEPP's modeled 1-to-3 session range is $2.18 โ $2.44, with a key inflection level at $2.40 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the ZEPP Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for ZEPP?
RSI at 35.4 reflects soft below-midline momentum. ZEPP trades at $2.31 relative to its 20-day SMA ($2.40) and 50-day SMA ($3.21), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.